Pentavalent organoantimonial derivatives:: two simple and efficient synthetic methods for meglumine antimonate

被引:39
作者
Demicheli, C
Ochoa, R
Lula, IS
Gozzo, FC
Eberlin, MN
Frézard, F
机构
[1] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Estadual Campinas, Inst Quim, BR-13083970 Campinas, SP, Brazil
[3] Univ Fed Minas Gerais, Dept Biofis & Fisiol, BR-31270901 Belo Horizonte, MG, Brazil
关键词
meglumine antimonate; glucantime; antimony; leishmaniasis; chemotherapy;
D O I
10.1002/aoc.425
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Two simple and efficient procedures for the preparation of pentavalent antimony derivatives are described, using either antimony pentachloride (SbCl5) or potassium hexahydroxoantimonate (KSb(OH)(6)) as sources of antimony(V). These two new methods are evaluated for the synthesis of an important anti-leishmanial drug: meglumine antimonate. Using elemental (carbon, hydrogen, nitrogen) and thermal analysis, atomic absorption (antimony), proton NMR spectroscopy and high-resolution positive-ion electrospray ionization- mass spectrometry (ESI(+)-MS), products for the reaction with N-methyl-D-glucamine (NMG) using both the SbCl5 and KSb(OH)(6) methods were characterized and found to be similar to a commercial sample of the drug. The only notable difference was observed for the ESI-MS spectrum of the KSb(OH)(6) product, it displays the same pattern of ESI-generated ions as those of both the SbCl5 Product and the commercial drug, but with significantly different abundance ratios. NMR data indicate that the NMG molecules coordinate antimony in two different fashions, which suggests either the coexistence of two different complexes or the existence of a single major complex in which two NMG molecules are coordinated with antimony in an asymmetrical geometry. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 13 条
[1]  
BAZACO F, Patent No. 2050614
[2]  
BERMAN JD, 1988, REV INFECT DIS, V10, P560
[3]   Antimony(V) complex formation with adenine nuelcosides in aqueous solution [J].
Demicheli, C ;
Frézard, F ;
Lecouvey, M ;
Garnier-Suillerot, A .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1570 (03) :192-198
[4]   Physico-chemical characterization of meglumine antimoniate [J].
Demicheli, C ;
de Figueiredo, TL ;
Carvalho, S ;
Sinesterra, RD ;
Lopes, JCD ;
Frézard, F .
BIOMETALS, 1999, 12 (01) :63-66
[5]  
DEMICHELI C, Patent No. 01063057
[6]  
DEMICHELI C, 1909, Patent No. 99075750
[7]   Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate [J].
Frézard, F ;
DeMicheli, C ;
Ferreira, CS ;
Costa, MAP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :913-916
[8]  
GAILLIOT PL, Patent No. 868747
[9]   FAST-ATOM-BOMBARDMENT MASS-SPECTROMETRY OF THE ORGANOMETALLIC PARASITICIDE, MEGLUMINE ANTIMONATE [J].
HEADLEY, JV ;
YONG, MS ;
BROOKS, PW ;
PHILLIPS, A .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1995, 9 (05) :372-376
[10]  
Marsden P. D., 1985, Revista da Sociedade Brasileira de Medicina Tropical, V18, P187, DOI 10.1590/S0037-86821985000300011